Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Johnson & Johnson Announces 8.8% Indirect Stake in Galapagos NV


Tuesday, 4 Sep 2012 12:01pm EDT 

Galapagos NV (Galapagos) announced that on August 30, 2012, it received a transparency notification from Johnson & Johnson and Galapagos co-founders Tibotec-Virco Comm. VA (Tibotec-Virco) and Crucell Holland B.V. (Crucell). Johnson & Johnson notified that, as a result of its acquisition of Crucell on February 22, 2011, Johnson & Johnson indirectly held 2,350,061 Galapagos shares through Tibotec-Virco and Crucell, which represents 8.8% of the 26,577,554 Galapagos shares outstanding as of September 4, 2012. The total number of the Company's shares held by these entities under Johnson & Johnson's control (Tibotec-Virco 1,113,964 shares and Crucell 1,236,097 shares), remains unchanged compared to previous notifications made by these companies. 

Company Quote

98.96
0.21 +0.21%
17 Apr 2014